Results: 3

1.
Figure 2

Figure 2. From: Omega-3 Fatty Acids and Vitamin D in Cardiology.

Physiological effects of n-3 PUFA that might influence cardiovascular disease (CVD) risk [9].

Norbert Güttler, et al. Cardiol Res Pract. 2012;2012:729670.
2.
Figure 3

Figure 3. From: Omega-3 Fatty Acids and Vitamin D in Cardiology.

Possible mechanism of increased cardiovascular (CV) risk from vitamin D deficiency. PTH: parathyroid hormone; RAAS: renin-angiotensin-aldosterone system.

Norbert Güttler, et al. Cardiol Res Pract. 2012;2012:729670.
3.
Figure 1

Figure 1. From: Omega-3 Fatty Acids and Vitamin D in Cardiology.

Molecular pathways affected by n-3 PUFA [9]. AA: arachidonic acid; COX: cyclooxogenase; cPLA2: cytosolic phospholipase A2; CYP450: cytochrome P450; DHA: docosahexaenoic acid; DNA: deoxyribonucleic acid; ERK: extracellular signal-regulated kinase; GPR 120: G-protein-coupled receptor 120; HNF: hepatic nuclear factor; LOX: lipoxygenase; mRNA: messenger ribonucleic acid; n-3 FA: n-3 fatty acids; NF-κB: nuclear factor-kappaB; PGE2: prostaglandin E2; PMN: polymorphonuclear leukocyte; PPAR: peroxisome proliferator-activated receptor; RXR: retinoid X receptor; SREBP-1c: sterol regulatory element binding protein-1c.

Norbert Güttler, et al. Cardiol Res Pract. 2012;2012:729670.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk